Alto Neuroscience, a clinical-stage biopharmaceutical company in the U.S., focuses on developing innovative treatments for mental health disorders. Their product pipeline includes drugs for bipolar depression, major depressive disorder, schizophrenia, and more.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing